Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SANTYL 250 UNIT — DIN 02063670

COLLAGENASE : 250 UNIT · SMITH & NEPHEW INC · OINTMENT · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is SANTYL?

SANTYL 250 UNIT contains COLLAGENASE : 250 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02063670, held by SMITH & NEPHEW INC, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Jan-2026. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

What is SANTYL used for?

SANTYL Ointment is a sterile ointment indicated for the debridement of dermal ulcers or severely burned areas. Rapid debridement contributes toward the formation of granulation tissue and subsequent epithelization of these lesions.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label250 UNIT
Dosage formOINTMENT
RouteTOPICAL
Pack configuration (monograph)30 gram tubes
Storagenull

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceCollagenase
ATC codeD03BA02
AHFS class84:92.00
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02063670
DIN (unpadded, as printed on some documents)2063670
Brand nameSANTYL
Generic / active ingredientCOLLAGENASE : 250 UNIT
Market authorization holderSMITH & NEPHEW INC
Health Canada schedulePrescription
ATC codeD03BA02
ATC anatomical main groupD — Dermatologicals
ATC therapeutic subgroupD03BA
Current statusCANCELLED POST MARKET
Status date28-Jan-2026
Original market date1994-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

2 · Same class — other molecules in ATC D03BA

MoleculeCanadian brandsDINsMarketedSourceable
Proteolytic EnzymesELASE CHLOROMYCETIN ONT · ELASE ONT · TRAVASE OINTMENT 82000 CASEIN UNITS/GM30Not in Canada
CollagenaseSANTYL10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02063670. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.